|

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

RECRUITINGSponsored by Dana-Farber Cancer Institute
Actively Recruiting
SponsorDana-Farber Cancer Institute
Started2004-08-09
Est. completion2033-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Any individual diagnosed with non-Hodgkin's lymphoma or Hodgkin's disease or chronic lymphocytic leukemia (CLL), who has a 1st degree relative (parent, sibling or child) with a lymphoproliferative disorder; or families in which the individual has a lymphoproliferative disorder, and an unusual clustering of frequent or premature solid tumors is also observed.
* Family members of the individual, either affected or unaffected with lymphoma, who are contacted by the individual and agree to participate in the study.
* Deceased family members may be included in the study. Public records such as death certificates may be used to confirm the history. Consent for medical records or tissue blocks will be obtained from the deceased family member's next of kin. The hierarchy of relatives defined as next of kin is spouse, offspring, parents and siblings. Archived tissue samples may be used for genetic research.
* Age \> 18 years

Exclusion Criteria:

* Subjects without a family history of lymphoma

Conditions5

CancerHodgkin's DiseaseLeukemia, Lymphocytic, ChronicLymphoproliferative DisordersNon-Hodgkin's Lymphoma

Locations1 site

Dana-Farber Cancer Institute
Boston, Massachusetts, 02115
Jennifer R. Brown, MD, PhD617-632-6692jennifer_brown@dfci.harvard.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.